Towards a molecular algorithm predicting glioma treatment response and resistance: A biomarker analysis and path to real time profiling in N2M2

Authors :: Frank Winkler
Michael Platten
Andreas Unterberg
Benedikt Brors
Juergen Debus
Felix Sahm
Anne Berberich
David T.W. Jones
Irini Karapanagiotou-Schenkel
Wolfgang Wick
Gnana Prakash Balasubramanian
Martin Bendszus
Susan Dettmer
Christel Herold-Mende
Tobias Kessler
Stefan M. Pfister
Elke Pfaff
Andreas von Deimling
Antje Wick
Source :: Journal of Clinical Oncology. 36:12090-12090
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 12090Background: Gliomas regularly evade current therapies through primary and acquired resistance and the effect of temozolomide is mainly restricted to the subgroup of methylguanin-O6-methyltrans...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Treatment response
Temozolomide
business.industry
medicine.disease
Acquired resistance
Internal medicine
Glioma
medicine
Biomarker Analysis
business
medicine.drug

Tools